Dogwood Therapeutics Inc expected to post a loss of $1.18 a share - Earnings Preview

Dogwood Therapeutics

06/11/2024 14:11

* Dogwood Therapeutics Inc  DWTX.OQ   DWTX.O  is expected
to show
no change in quarterly revenue when it reports  results on
November 7 for the period ending September 30 2024
    * 
    * ​LSEG's mean analyst estimate for Dogwood Therapeutics Inc
is
for a loss of $1.18 per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Dogwood
Therapeutics Inc is 25.00​, above​ its last closing price
of $4.62. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Jun. 30 2024  -1.56       -1.58      -1.25     Beat    21
 Jan. 1 2024   -1.00                  -1.75             -75
 Jan. 1 0001   -2.24                  -1.50             33.3​
 Sep. 30 2023  -2.37       -2.37      -1.50     Beat    36.8
 ​​Jan.        -1.75       -1.75      -2.00     Missed  -14.3
 1 0001                                                 
 Mar. 31 2023  -5.00       -5.00      -2.00     Beat    60​
 Jan. 1 0001   -3.87       -3.87      -2.75     Beat    29
 Jan. 1 0001   -11.50      -12.25     -7.00     Beat    42.9
 This summary was machine generated November 6 at 14:10 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)